|
Characteristic
|
High-income patient
|
Middle/low-income patient
|
Slum resident patient
|
P value
|
|---|
|
n
|
%
|
N
|
%
|
N
|
%
|
|---|
|
S. aureus colonization
|
94
|
32
|
51
|
41
|
76
|
42
|
0.09
|
|
MSSA colonization
|
77
|
27
|
33
|
26
|
62
|
34
|
0.19
|
|
MRSA colonization
|
17
|
6
|
18
|
14
|
14
|
8
|
0.01
|
|
MRSA SCCmec type
| | | | | | |
0.31
|
|
Type I
|
0
|
0
|
1
|
6
|
0
|
0
| |
|
Type II
|
0
|
0
|
1
|
6
|
0
|
0
| |
|
Type III
|
1
|
6
|
1
|
6
|
1
|
7
| |
|
Type IV
|
13
|
77
|
15
|
83
|
13
|
93
| |
|
Type V
|
3
|
18
|
0
|
0
|
0
|
0
| |
|
Presence of PVL gene in MRSA isolate
|
4
|
19
|
2
|
10
|
4
|
21
|
0.57
|
|
Streptococcal colonization
|
8
|
3
|
7
|
6
|
9
|
5
|
0.30
|
|
Streptococcal Lancefield group
| | | | | | |
0.001
|
|
Group A
|
8
|
100
|
1
|
14
|
6
|
67
| |
|
Group B
|
0
|
0
|
5
|
71
|
0
|
0
| |
|
Group C or G
|
0
|
0
|
1
|
14
|
3
|
33
| |
- MSSA methicillin-susceptible Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus, PVL Panton-Valentine leucocidin
